Navigation Links
Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
Date:4/27/2009

SAN DIEGO, April 27 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that Michael C. Scaife, Ph.D., has joined the organization as Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program.

"Michael brings to Orexigen over 26 years of solid experience in biotechnology and pharmaceutical product development, including 15 successful product approvals by the FDA," said Michael Narachi, the Company's President and Chief Executive Officer. "His appointment is timely as our foremost priority is to submit to the FDA the highest quality NDA and bring Contrave, our lead obesity product candidate, to market expeditiously."

In his role, Dr. Scaife will lead the development of Contrave (naltrexone sustained release (SR)/bupropion SR), which is on track for submission to the FDA in the first half of 2010. "I'm thrilled to join the Orexigen team, and I believe my development and regulatory experience will be invaluable as the Company works to help fill a significant unmet need in the fight against obesity," said Dr. Scaife.

Dr. Scaife has worked in leadership roles for a variety of device, drug and biopharma companies in both Europe and the United States. Prior to joining Orexigen, Dr. Scaife was Principal of MChS Consultancy Inc., a leading pharmaceutical development services agency. He also served as Senior Vice President of Global Regulatory Affairs, Pharmacovigilance and Drug Safety, Drug Information Services, Compliance and Quality Operations at Chiron Biopharma. In addition, Dr. Scaife held the position of Vice President of Quality and Regulatory Affairs for Nektar Therapeutics, Vice President of Global Regulatory Affairs for Elan Pharmaceuticals, and various regulatory an
'/>"/>

SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Orexigen(R) Therapeutics Schedules March 12, 2009 Webcast Discussion of Financial Results for the Fourth Quarter and Year Ended December 31, 2008
2. Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
3. Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
4. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
5. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
6. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
7. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
8. Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
9. Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
10. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
11. United Therapeutics to Announce 2009 First Quarter Financial Results Before Market Open on Friday, May 1, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Adding ... their weighing boat special – Buy 2 ... free. This promotion will benefit lab technicians looking for ... Weighing boats are ideal for multiple applications including weighing ... a variety of choices including diamond-shaped, hexagonal, square, aluminum ...
(Date:7/29/2014)... Boston, MA (PRWEB) July 30, 2014 ... communication (UC) and collaboration company, is proud to ... and account management positions in their Boston, Charleston ... in response to the increased demand for hosted ... enhance operational efficiency and reduce cost. , SoundConnect ...
(Date:7/29/2014)... The advanced optical methods and applications ... driving a revolution in the neurosciences were the inspiration ... by SPIE, the international society for optics and ... launch of the BRAIN Initiative in the United States, ... a vision for and provide examples of the impact ...
(Date:7/29/2014)... Quantum Cheshire Cat: Can a particle be separated from ... Nature Communications , published the results of the first ... field, conducted by Chapman University in Orange, CA, and ... seen a cat without a grin," thought Alice in ... most curious thing I ever saw in my life!" ...
Breaking Biology Technology:Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2SoundConnect Organization and Culture is Evolving 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 2SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 3SPIE Launches 'Neurophotonics' Journal with Special Section on BRAIN Initiative 4The quantum Cheshire cat: Scientists separate a particle from its properties 2The quantum Cheshire cat: Scientists separate a particle from its properties 3The quantum Cheshire cat: Scientists separate a particle from its properties 4
... Kingchem to Act as Agent to Find Partner ... for North American MarketsLAS VEGAS, April 3 ... Board: SNBP) ("Sinobiopharma") (the "Company") is pleased to ... export agreement with Kingchem, an international marketing organization ...
... ChromaDex Corporation, (OTC Bulletin Board: CDXC) a ... today announced financial results for the 2008 Fiscal ... with U.S. Generally Accepted Accounting Principles (U.S. GAAP), ... stockholders of $0.07 per share for the twelve ...
... April 3 Savient Pharmaceuticals, Inc. (Nasdaq: ... definitive agreements with select existing and new institutional investors ... share of its common stock, $0.01 par value per ... of its common stock in a registered direct offering ...
Cached Biology Technology:Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier 2ChromaDex Announces 2008 Year End Financial Results 2ChromaDex Announces 2008 Year End Financial Results 3Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering 2Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering 3Savient Pharmaceuticals to Raise $31 Million Through Registered Direct Offering 4
(Date:7/28/2014)... professor John Essigmann and colleagues from the University of Washington ... if they could induce the virus to mutate uncontrollably, they ... a strategy that our immune system uses against many viruses. ... HIV to mutate at an enhanced rate, as expected. But ... small clinical trial reported in 2011. In a new study, ...
(Date:7/28/2014)... of Solanum pennellii , a wild relative of ... group of researchers including the labs headed by Professors ... Department of Plant Biology. The new genome information may ... work, published July 27 in the journal Nature ... at Aachen University in Germany. The UC Davis labs ...
(Date:7/28/2014)... new study suggest two ways to effectively address the problem ... obese women, compared to women of a normal body mass ... say, but as the population has increased in weight, concern ... women. Studies have consistently found that obesity has a negative ... turn affect how well the pill prevents pregnancy. ...
Breaking Biology News(10 mins):Forced mutations doom HIV 2Forced mutations doom HIV 3Forced mutations doom HIV 4Strategies identified to improve oral contraceptive success with obese women 2
... synchrotron-based imaging techniques to identify previously unseen anatomy preserved in ... old lizard skin identified the presence of teeth (invisible to ... animal was more than just a skin moult. This was ... universe, x-rays generated by a synchrotron. Dr Phil ...
... , This press release is available in ... researcher at the Centre for Studies on Human Stress (CSHS) ... de Montral suggests that bullying by peers changes the structure ... vulnerable to mental health problems as they age. The ...
... As the federal government builds on its $1 billion investment ... research consortium has developed innovative new maps of both environmental ... remediation of the world,s largest fresh water resource. Writing ... the National Academy of Science ( PNAS ), a ...
Cached Biology News:Prehistoric ghosts revealing new details 2Bullying by childhood peers leaves a trace that can change the expression of a gene linked to mood 2Mapping effort charts restoration tack for Great Lakes 2Mapping effort charts restoration tack for Great Lakes 3